Anthracyclines, a type of chemotherapy drug, produce type I interferon (IFN) after activating the endosomal pattern recognition receptor Toll-like receptor 3 (TLR3), which binds to IFN-α and IFN-β receptors (IFNAR) on tumor cells. Here, IFNA1 is linked to neoplasm.